ENTRY       C00064                      Compound
NAME        L-Glutamine;
            L-2-Aminoglutaramic acid
FORMULA     C5H10N2O3
EXACT_MASS  146.0691
MOL_WEIGHT  146.1445
REMARK      Same as: D00015
REACTION    R00021 R00093 R00114 R00253 R00256 R00257 R00573 R00575 
            R00576 R00577 R00578 R00579 R00768 R00986 R01072 R01149 
            R01231 R01375 R01716 R02576 R02781 R02895 R03652 R03905 
            R04011 R04212 R04463 R04558 R05224 R05225 R05815 R07456 
            R08244 R08855 R08890 R08891 R08956 R09195 R09598 R09599 
            R10089 R11515 R11627 R11941 R12352 R12478 R12507 R12590 
            R12939
PATHWAY     map00220  Arginine biosynthesis
            map00230  Purine metabolism
            map00240  Pyrimidine metabolism
            map00250  Alanine, aspartate and glutamate metabolism
            map00470  D-Amino acid metabolism
            map00630  Glyoxylate and dicarboxylate metabolism
            map00750  Vitamin B6 metabolism
            map00910  Nitrogen metabolism
            map00970  Aminoacyl-tRNA biosynthesis
            map01060  Biosynthesis of plant secondary metabolites
            map01100  Metabolic pathways
            map01120  Microbial metabolism in diverse environments
            map01230  Biosynthesis of amino acids
            map01232  Nucleotide metabolism
            map01240  Biosynthesis of cofactors
            map02010  ABC transporters
            map02020  Two-component system
            map04724  Glutamatergic synapse
            map04727  GABAergic synapse
            map04964  Proximal tubule bicarbonate reclamation
            map04974  Protein digestion and absorption
            map04978  Mineral absorption
            map05230  Central carbon metabolism in cancer
MODULE      M00048  De novo purine biosynthesis, PRPP + glutamine => IMP
            M00051  De novo pyrimidine biosynthesis, glutamine (+ PRPP) => UMP
            M00916  Pyridoxal-P biosynthesis, R5P + glyceraldehyde-3P + glutamine => pyridoxal-P
ENZYME      1.4.1.13        1.4.1.14        1.4.7.1         2.3.1.14        
            2.3.1.68        2.3.2.1         2.3.2.14        2.4.2.14        
            2.6.1.15        2.6.1.16        2.6.1.50        2.6.1.64        
            2.6.1.85        2.6.1.86        2.6.1.100       2.6.1.101       
            2.6.1.117       2.6.1.123       2.7.3.13        3.5.1.2         
            3.5.1.38        3.5.1.133       4.1.3.27        4.3.2.10        
            4.3.3.6         5.1.1.10        6.1.1.18        6.3.1.2         
            6.3.4.2         6.3.5.1         6.3.5.2         6.3.5.3         
            6.3.5.4         6.3.5.5         6.3.5.6         6.3.5.7         
            6.3.5.9         6.3.5.10        6.3.5.11        6.3.5.12        
            6.3.5.13        6.3.5.-
BRITE       Compounds with biological roles [BR:br08001]
             Peptides
              Amino acids
               Common amino acids
                C00064  Glutamine (Gln)
            Anatomical Therapeutic Chemical (ATC) classification [BR:br08303(D00015)]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AA Amino acids and derivatives
                 A16AA03 Glutamine
                  D00015  Glutamine (USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302(D00015)]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Glutamine
               D00015  Glutamine (USP)
            Therapeutic category of drugs in Japan [BR:br08301(D00015)]
             2  Agents affecting individual organs
              23  Digestive organ agents
               232  Peptic ulcer agents
                2322  Glutamines
                 D00015  Glutamine (USP); L-Glutamine (JP18)
            Risk category of Japanese OTC drugs [BR:br08312(D00015)]
             Third-class OTC drugs
              Inorganic and organic chemicals
               L-Glutamine
                D00015  Glutamine (USP)
            Drug groups [BR:br08330(D00015)]
             Gastrointestinal agent
              DG01975  Agents for peptic ulcer
               DG02008  Gastric mucosal protectant
                D00015  Glutamine
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311(D00015)]
             Chemicals
              D00015  L-Glutamine
            New drug approvals in the USA [br08319.html(D00015)]
             New molecular entities and new therapeutic biological products
              D00015
            New drug approvals in the USA, Europe and Japan [br08328.html(D00015)]
             Approval dates by FDA, EMA and PMDA
              D00015
DBLINKS     CAS: 56-85-9
            PubChem: 3364
            ChEBI: 18050
            KNApSAcK: C00001359
            PDB-CCD: GLN
            3DMET: B00017
            NIKKAJI: J9.170G
ATOM        10
            1   C1c C    23.8378  -17.4606
            2   C1b C    25.0254  -16.7178
            3   C6a C    22.6035  -16.7995
            4   N1a N    23.8787  -18.8587
            5   C1b C    26.2597  -17.3787
            6   O6a O    21.4451  -17.5952
            7   O6a O    22.6209  -15.4015
            8   C5a C    27.4472  -16.6416
            9   N1a N    28.6814  -17.3027
            10  O5a O    27.4704  -15.2435
BOND        9
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     3   6 1
            6     3   7 2
            7     5   8 1
            8     8   9 1
            9     8  10 2
///
